Pipeline Trigger: Character Biosciences Intel
Series B extension + new CMO at Character Biosciences unlock AMD trial pipeline. Pitch AI-driven patient strat to speed deal flow and hit quota.
Published on
Do not index
Do not index
🚀 Battle Card: Character Biosciences
Quick trigger:
👤 Decision Maker in the News
- Robert Kim, M.D., MBA, Chief Medical Officer · 🔗 LinkedIn
💡 Why It Matters
- Series B extension and KOL hires unlock clinic-ready AMD programs. Use this Character Biosciences sales trigger to align on AI-driven trial acceleration. → Source
🎯 Core Pain Point
- Accelerating clinical-stage development in ophthalmology
- Securing expert leadership to scale R&D and operations
💰 What to Pitch
- Primary: AI-driven patient stratification platform → Reduce trial failure and speed go-to-clinic
- Expansion: Genomics data integration service → Enhance precision targeting for AMD and POAG
🗺️ Quick Context
- HQ: Jersey City, NJ
- Employees: ≈ 75
- Rev: ≈ $0 (pre-revenue biotech)
- Website: characterbio.com
Deliver insights from this Character Biosciences sales trigger to stand out.
🤼 Competitive Intel
*Which other vendors you’ll probably face to win Character Biosciences’s business.*
Product/Engineering
- Veeva Systems — Clinical Data Mgmt.
- Unique edge: end-to-end pharma cloud
- Evaluated by Chief Data & Analytics Officer for integration depth
- Benchling — R&D Cloud
- Unique edge: seamless lab-to-clinic data flow
- Evaluated by Head of Clinical Network for collaboration tools
- Medidata — Clinical Trial Analytics
- Unique edge: AI-driven trial optimization
- Evaluated by CMO & CSO for predictive modeling
Ops & Supply Chain
- TraceLink — Supply Network
- Unique edge: real-time visibility across sites
- Evaluated by VP Ops for compliance tracking
- SAP — ERP & SCM
- Unique edge: robust global supply modules
- Evaluated by CFO & VP Ops for scalability
- Oracle SCM Cloud — Supply Chain Cloud
- Unique edge: integrated procurement to delivery
- Evaluated by VP Ops for end-to-end workflow
HR & People
- Workday — HCM & Recruiting
- Unique edge: unified finance & HR data
- Evaluated by Head of People for actionable insights
- Greenhouse — Talent Acquisition
- Unique edge: structured hiring workflows
- Evaluated by Head of People for candidate pipeline visibility
- Lattice — People Management
- Unique edge: continuous performance feedback
- Evaluated by Head of People for engagement analytics
✅ Do-Now Checklist
Connect with Robert Kim on LinkedIn (link above)
Craft first touch using this Character Biosciences sales trigger in your pitch
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑❑
OFFER_BRIEF = ❑AI-driven patient stratification platform❑
PROOF_METRIC = ❑20% reduction in trial failures❑
CTA_STYLE = ❑quick_call❑
TONE = ❑friendly❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Robert
COMPANY = Character Biosciences
DEPT = Clinical
SIZE = ≈ TBD
BOTTLENECK = scaling clinical development operations
EVENT = leadership team expansion
DETAIL = Series B extension
PAIN = Accelerating clinical-stage development in ophthalmology
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250917389360&div=41152219
SIM_CO = ≈ TBD
WIN_METRIC = ≈ TBD
NEXT_SIZE = ≈ 150
EMP_EST = ≈ 75
REV_EST = ≈ 0
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: ≈ TBD-person Clinical
Robert—noticed your Clinical team is ≈ TBD.
That’s when scaling clinical development operations slows growth.
We helped ≈ TBD fix this with AI-driven patient stratification platform.
Result: ≈ TBD.
Quick call?
PS—next bottleneck hits ≈ 150.
DM ≤45 words, TONE:
Saw your post about Series B extension — Accelerating clinical-stage development in ophthalmology.
AI-driven patient stratification platform. 20% reduction in trial failures.
Quick chat?```